Akero Therapeutics

AKRO

54.6500.00% ( 0.000 )

Delisted: Dec 8, 16:00:00 (EDT)

Forecast & Rating7 analysts currently cover Akero Therapeutics, with about 14.3% giving a positive rating — meaning they expect the stock to rise. For you, this means most institutions are cautious on Akero Therapeutics's outlook. Data as of Dec 8, 2025; for reference only and not investment advice.

Nov 13, 2025

Price forecast

--100.00%

Forecast & RatingHold

7analysts

Forecast dateDec 8, 2025

Forecast met0.0%

Stock price$54.65

Avg. target$0.0

High target$58

Low target$54

Strong buy

Buy

Hold

Sell

Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.